Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Secukinumab two injections?

See the DrugPatentWatch profile for Secukinumab

What to Expect After Receiving Secukinumab via Two Injections

Secukinumab is a biologic medication used to treat moderate to severe plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. It works by blocking the action of a protein called interleukin-17A (IL-17A), which plays a key role in inflammation and skin cell growth.

When Can I Expect Results?

Improvements in psoriasis symptoms, such as reduced plaque size and inflammation, are typically seen within 24 to 40 weeks of starting secukinumab treatment [2]. However, individual results may vary, and some patients may see significant improvements earlier.

Common Side Effects After Two Injections

After receiving two injections of secukinumab, some common side effects may include injection site reactions, such as redness, swelling, or itching [3]. These reactions are usually mild and temporary. Less common side effects include headaches, fatigue, and diarrhea.

Long-Term Safety

Secukinumab has been studied in clinical trials for extended periods, and the data suggest that it is generally well-tolerated [4]. However, as with any medication, long-term use may increase the risk of side effects. Regular monitoring and follow-up appointments with your healthcare provider are essential.

Why Are Biosimilars Not Available Yet?

Secukinumab is still under patent protection, which limits the availability of biosimilars [5]. Biosimilars are interchangeable versions of biologic medications, which can offer more affordable treatment options. The patent for secukinumab is set to expire in 2028.

What Should I Do If I Have Questions or Concerns?

If you have questions or concerns about secukinumab or its potential side effects, talk to your healthcare provider or a registered nurse. They can provide personalized guidance and support throughout your treatment journey.

Sources:

[1] https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/125537s000lbl.pdf

[2] https://www.sciencedirect.com/science/article/pii/S0026529515001415

[3] https://www.drugs.com/side-effects/secukinumab.html

[4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744457/

[5] https://www.drugpatentwatch.com/US-D/US125537



Other Questions About Secukinumab :

Secukinumab dose in psoriasis? Secukinumab monitoring? What drugs cause interactions with secukinumab? Secukinumab and covid vaccines? Are there any food interactions I should avoid with secukinumab? Secukinumab renal impairment?